Inventor · disambiguated record
Guy L. Reed
Also filed as: REED GUY · REED GUY L
26 granted patents·7 pending applications·156 citations·filing 1992–2023
95Inventor score
Top patents by PatentIndex Score
33 records- 0184US9834614B2Method of increasing plasmin activity through antiplasmin conversionTRANSLATIONAL SCIENCES INC·Filed 2015·Granted Dec 5, 2017·2 cites·25 claims
- 0283US9150903B2Method of increasing plasmin activity through antiplasmin conversionREED GUY L·Filed 2008·Granted Oct 6, 2015·4 cites·17 claims
- 0376US10160813B2Tissue plasminogen activator antibodies and methods of useUNIV TENNESSEE RES FOUND·Filed 2014·Granted Dec 25, 2018·2 cites·15 claims
- 0476US5582862AAntibodies that bind to α2-antiplasmin crosslinked to fibrin which do not inhibit plasma α2-antiplasminGEN HOSPITAL CORP·Filed 1992·Granted Dec 10, 1996·26 cites·13 claims
- 0567US2022298262A1Inhibition of Vascular Matrix Metalloproteinase-9 to Treat Ischemic InjuryTRANSLATIONAL SCIENCES INC·Filed 2022·Application pending·0 cites
- 0664US2025312409A1Methods of treating dilated cardiomyopathy and heart failureUNIV ARIZONA·Filed 2023·Application pending·0 cites
- 0763US2022298261A1Serpinf2-Binding Molecules and Method of Use ThereofTRANSLATIONAL SCIENCES INC·Filed 2022·Application pending·0 cites
- 0862US10676539B2Tissue plasminogen activator antibodies and methods of useUNIV TENNESSEE RES FOUND·Filed 2018·Granted Jun 9, 2020·0 cites·4 claims
- 0961US5332665ASpecies specific, high affinity monoclonal antibodiesGEN HOSPITAL CORP·Filed 1993·Granted Jul 26, 1994·18 cites·5 claims
- 1060US11236176B2Serpinf2-binding molecules and method of use thereofTRANSLATIONAL SCIENCES INC·Filed 2014·Granted Feb 1, 2022·0 cites·17 claims
- 1159US6114506AComposition and method for enhancing fibrinolysisGEN HOSPITAL CORP·Filed 1997·Granted Sep 5, 2000·14 cites·8 claims
- 1257US5854049APlasmin-resistant streptokinaseHARVARD COLLEGE·Filed 1995·Granted Dec 29, 1998·18 cites·8 claims
- 1356US11345758B2Inhibition of vascular matrix metalloproteinase-9 to treat ischemic injuryTRANSLATIONAL SCIENCES INC·Filed 2018·Granted May 31, 2022·0 cites·14 claims
- 1455US5773228AActivation-dependent protein expressed on the surface of activated platelets and antibodies theretoGEN HOSPITAL CORP·Filed 1995·Granted Jun 30, 1998·8 cites·25 claims
- 1554US5939540APlatelet secretory transport proteinHARVARD COLLEGE·Filed 1997·Granted Aug 17, 1999·7 cites·10 claims
- 1654US2021262008A1Method of personalized treatment for cardiomyopathy and heart failure and other related diseases by measuring renin activity, pro-renin, pro-renin receptor levels in bloodUNIV ARIZONA·Filed 2021·Application pending·0 cites
- 1753US6750323B1Platelet activation proteinHARVARD COLLEGE·Filed 2000·Granted Jun 15, 2004·0 cites·2 claims
- 1852US5446132AThrombin-activated platelet protein-2 (TAPP-2)GEN HOSPITAL CORP·Filed 1992·Granted Aug 29, 1995·10 cites·2 claims
- 1951US5620688AMethods of inhibiting the activation of Factor XIIIBRISTOL MYERS SQUIBB CO·Filed 1992·Granted Apr 15, 1997·11 cites·8 claims
- 2051US2004235115A1Compositions and methods for treating thrombotic disordersFiled 2003·Application pending·0 cites
- 2150US2021263120A1Method of personalized treatment for cardiomyopathy and heart failure and associated diseases by measuring edema and cachexia/sarcopeniaUNIV ARIZONA·Filed 2021·Application pending·0 cites
- 2247US11078297B2Prophylaxis of thrombosisTRANSLATIONAL SCIENCES INC·Filed 2015·Granted Aug 3, 2021·0 cites·10 claims
- 2347US11066482B2Specific plasmin inactivation by anticatalytic antibodyREED GUY L·Filed 2018·Granted Jul 20, 2021·0 cites·19 claims
- 2446US5470957AImmunoinhibitors of factor XIIIHARVARD COLLEGE·Filed 1993·Granted Nov 28, 1995·7 cites·2 claims
- 2546US2003031664A1Composition and method for enhancing fibrinolysisGEN HOSPITAL CORP·Filed 2001·Application pending·0 cites
- 2645US6534035B1Methods of inhibiting clot formationHARVARD COLLEGE·Filed 1999·Granted Mar 18, 2003·8 cites·8 claims
- 2742USD397885SDisplay case for photographs and cards resembling a baseball batREED GUY·Filed 1997·Granted Sep 8, 1998·6 cites·1 claims
- 2842US5372812AComposition and method for acceleration of clot lysisGEN HOSPITAL CORP·Filed 1992·Granted Dec 13, 1994·8 cites·11 claims
- 2940US5831031AAntibodies that bind to α2-antiplasmin crosslinked to fibrin which do not inhibit plasma α2-antiplasminGEN HOSPITAL CORP·Filed 1996·Granted Nov 3, 1998·1 cites·4 claims
- 3039US6210667B1Bacterial fibrin-dependent plasminogen activatorHARVARD COLLEGE·Filed 1998·Granted Apr 3, 2001·4 cites·11 claims
- 3137US6576431B2Antibodies that bind to α2-antiplasmin crosslinked to fibrin which do not inhibit plasma α2-antiplasminGEN HOSPITAL CORP·Filed 2001·Granted Jun 10, 2003·1 cites·2 claims
- 3235US6280730B1Antibodies that bind to α2-antiplasmin crosslinked to fibrin which do not inhibit plasma α2-antiplasminGEN HOSPITAL CORP·Filed 1997·Granted Aug 28, 2001·1 cites·10 claims
- 3329US6160108APlatelet activation proteinHARVARD COLLEGE·Filed 1996·Granted Dec 12, 2000·0 cites·23 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →